Received 21 April 1997/Returned for modification 30 June 1997/Accepted 28 August 1997

Size: px
Start display at page:

Download "Received 21 April 1997/Returned for modification 30 June 1997/Accepted 28 August 1997"

Transcription

1 JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1997, p Vol. 35, No /97/$ Copyright 1997, American Society for Microbiology Comparison of Agar Dilution, Broth Microdilution, E-Test, Disk Diffusion, and Automated Vitek Methods for Testing Susceptibilities of Enterococcus spp. to Vancomycin PEGGY C. KOHNER, 1 ROBIN PATEL, 2 JAMES R. UHL, 1 KAY M. GARIN, 3 MARLENE K. HOPKINS, 1 LEE T. WEGENER, 3 AND FRANKLIN R. COCKERILL III 1,2 * Division of Clinical Microbiology, Department of Laboratory Medicine, 1 and Division of Infectious Diseases, Department of Internal Medicine, 2 Mayo Clinic and Foundation, Rochester, Minnesota 55905, and Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Scottsdale, Arizona Received 21 April 1997/Returned for modification 30 June 1997/Accepted 28 August 1997 An evaluation was undertaken to determine the optimal method for testing the susceptibilities of 100 clinical isolates and two reference strains of Enterococcus spp. to vancomycin in vitro. Six testing methods were studied by using the following media and incubation times: agar screen with the Synergy Quad Plate (Remel, Lenexa, Kans.), an in-house-prepared brain heart infusion () agar plate, and an in-house-prepared Mueller-Hinton () agar plate, all incubated for 24 or 48 h; broth microdilution (Sensititre Just One Strip; AccuMed International, Inc., West Lake, Ohio) with or cation-adjusted broth incubated for 24 or 48 h; agar dilution with or agar incubated for 24 or 48 h; epsilometer test (E test; AB BioDisk, Solna, Sweden) with or agar incubated for 24 or 48 h; disk diffusion with or agar incubated for 24 or 48 h; and the automated Vitek method with the gram-positive susceptibility Staphylococcus aureus card and R02.03 software (biomerieux, Inc., Hazelwood, Mo.). Growth failures occurred with media (n 6) but not with media. One growth failure occurred with the Vitek method. Results for each testing method for each Enterococcus strain were interpreted as susceptible, intermediate, or resistant according to current National Committee for Clinical Laboratory Standards (NCCLS) criteria and compared to the vancomycin resistance genotype (i.e., vana, vanb, vanc-1, or vanc-2/3). For all methods, extension of the incubation time from 24 h to 48 h either produced no difference in the results or gave poorer results. The following methods produced no very major or major interpretive errors: broth microdilution with media incubated for 24 h, agar dilution with media incubated for 24 or 48 h, and E test with media incubated for 24 or 48 h. Unacceptable frequencies of very major errors (>1%) occurred with all methods for which media were used. Minor interpretive errors were frequent with all methods. These minor interpretive errors also occurred most frequently with Enterococcus strains with vanc genes, which encoded low-level vancomycin resistance (MIC < 8 g/ml), as opposed to Enterococcus strains which possessed vana or vanb genes, which encoded higher-level vancomycin resistance (MIC > 64 g/ml). Modification of NCCLS breakpoints, especially for motile Enterococcus spp. (E. casseliflavus, E. flavescens, and E. gallinarum), may resolve this problem; however, in the current study, one E. faecalis strain and one E. faecium strain carried only the vanc gene. The agar screen method may also require reformulation. The current agar screen plate contains 6 g of vancomycin per ml, which may not detect all low-level resistance associated with vanc genotypes. Nevertheless, the clinical significance of this low-level vancomycin resistance remains unknown. * Corresponding author. Mailing address: Division of Clinical Microbiology, Mayo Clinic, Hilton 460C, 200 First St. SW, Rochester, MN Phone: (507) Fax: (507) cock erill.franklin@mayo.edu. Identifying vancomycin-resistant Enterococcus spp. (VRE) is important so that patients receive appropriate antimicrobial therapy and nosocomial outbreaks can be prevented or controlled. We undertook this study to determine the optimal method for testing the susceptibilities of clinical isolates of Enterococcus spp. to vancomycin in vitro. We compared the performance characteristics of three agar screen plates (Synergy Quad Plate [Remel, Lenexa, Kans.] and two agar screen plates prepared in-house), agar dilution, broth microdilution (Sensititre Just One Strip; AccuMed International, Inc., Westlake, Ohio), the epsilometer test (E test; AB BioDisk, Solna, Sweden), disk diffusion, and the automated Vitek method (biomerieux, Inc., Hazelwood, Mo.). For all methods, excluding the Synergy Quad Plate and the Vitek methods, two different media, Mueller-Hinton () or brain heart infusion (), were used. Two different incubation periods, 24 and 48 h, were studied for all methods except the Vitek method. For the Vitek method, the gram-positive susceptibility Staphylococcus aureus (GPS-SA) cards, software version R02.03, and a minimum incubation time of 6 h were used. The susceptibility results for each of the 100 clinical isolates and two reference strains of Enterococcus spp. produced by these methods were interpreted according to 1995 National Committee for Clinical Laboratory Standards (NCCLS) guidelines (6) and compared to the vancomycin resistance genotype. Vancomycin resistance genotypes for each strain were determined by a multiplex PCR method developed in our laboratory (8) to detect the following genes which have been associated with glycopeptide resistance: vana, vanb, vanc1, vanc2, and vanc3. (Data from this paper were presented in part at the 96th General Meeting of the American Society for Microbiology, New Orleans, La., 19 to 23 May [poster C175]) 3258

2 VOL. 35, 1997 TESTING SUSCEPTIBILITIES OF ENTEROCOCCI TO VANCOMYCIN 3259 TABLE 1. Identification and van genes and phenotypes of Enterococcus clinical isolates a,b Gene(s) detected c No. of isolates Enterococcus spp. (no. of isolates) MIC ( g/ml) Several studies have evaluated the abilities of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in Enterococcus isolates (3, 9 16). Those studies which have evaluated current versions of automated or semiautomated commercial systems, such as the Vitek system (biomerieux, Inc.), the MicroScan Rapid system (Baxter Health Care Corp., West Sacramento, Calif.), or the Alamar MIC system (Alamar Biosciences, Sacramento, Calif.), have shown that these methods do not reliably detect vancomycin resistance in enterococci (11, 13, 15, 16). Reasons for the poor performance of these systems likely include the composition of growth media and the relatively short incubation times that are used. Most conventional broth- and agar-based manual methods require a full 24 h of incubation, and cur- Vancomycin Teicoplanin vana 10 E. faecium (8) (2) vana vanc-1 1 E. gallinarum (1) vanb 30 E. faecium (2) (1) (12) (10) (3) E. faecalis (1) (1) 64 8 vanc-1 12 E. gallinarum (5) 8 8 (5) 4 8 E. faecium (1) 8 8 E. faecalis (1) 4 8 vanc-2/3 6 E. casseliflavus/ flavescens (6) PCR amplicon produced but with distinct restriction fragment length pattern d E. faecalis (1) (1) E. casseliflavus/ flavescens (2) 4 8 None 37 E. casseliflavus/ 4 8 flavescens (2) E. faecalis (28) 2 8 (1) 4 8 E. faecium (4) 2 8 E. avium (1) 2 8 E. raffinosus (1) 2 8 a Modified from Table 2 in reference 8. b Species designations for all clinical isolates were previously determined by standard biochemical techniques, and MICs were determined by an agar dilution technique (8). c The multiplex PCR used to determine van genes will not discriminate the vanc-2 gene from the vanc-3 gene (8), which is therefore designated vanc-2/3. d DNA sequencing of the amplicons for the two E. faecalis isolates revealed nucleic acid sequences closely related to the published sequence for the vanb gene (1, 2). DNA sequencing of the amplicons for the two E. casseliflavus/ flavescens isolates revealed nucleic acid sequences closely related to the published sequences for vanc-2 and vanc-3 genes (7). MATERIALS AND METHODS One hundred Enterococcus clinical isolates (34 E. faecalis, 43E. faecium, 11 E. gallinarum, 10E. casseliflavus/flavescens, 1E. avium, and 1 E. raffinosus [Table 1]) and 2 reference strains (E. faecalis ATTC and ATTC 51299) were evaluated for their susceptibilities to vancomycin by different susceptibility test methods. In Table 1, species designations and vancomycin and teicoplanin MICs are shown for the Enterococcus clinical isolates. Species designations for these clinical isolates were previously determined by standard biochemical techniques, and MICs were previously determined by using media and an agar dilution technique (8). For the current study, the test media used, including whether the media were prepared in-house or commercially prepared, inocula, incubation parameters, and susceptibility interpretive guidelines are shown in Table 2. Except for the commercial methods, available NCCLS guidelines were followed for medium and bacterial inoculum preparation for agar dilution ( agar) (5), broth microdilution (cation-adjusted broth [CA broth]) (5) and disk diffusion ( agar) (4). The results for each method were also interpreted according to NCCLS guidelines (6). Therefore, the breakpoints used for interpretive categories were the following: susceptible, 4 g/ml, intermediate, 8 to 16 g/ml, and resistant, 32 g/ml. All Enterococcus isolates were previously surveyed for genes associated with vancomycin resistance by using a multiplex PCR and restriction fragment length polymorphism (RFLP) analysis previously described by us (8). These results are shown in Table 1. By this PCR-RFLP method, the vana, vanb, vanc1, vanc2, and vanc3 genes are identified; however, the vanc2 and vanc3 genes, although amplified, cannot be discriminated from one another. We therefore designate the vanc2 and vanc3 genes vanc-2/3. The susceptibility results for all Enterococcus strains for all methods were compared to the vancomycin genotypes for these strains. RESULTS Table 3 shows the susceptibility testing results compared to the vancomycin genotype for individual Enterococcus species. There were no growth failures with media. Furthermore, there appeared to be more luxuriant growth with media, making the results easier to interpret. Six strains failed to grow on media incubated for either 24 h or 48 h (two with microbroth dilution, one with agar dilution, two with E test, and one with disk diffusion). One growth failure occurred with the Vitek method. For all methods, extension of the incubation time from 24 h to 48 h either produced no difference in the results or gave poorer results. Table 4 summarizes all of the interpretive errors for each method for all of the Enterococcus spp. combined. The following methods produced no very major (resistant strains misinterpreted as susceptible, i.e., false susceptibility) or major (susceptible strains misinterpreted as resistant, i.e., false resistance) interpretive errors when the results were compared to those for the vancomycin resistance genotype: broth microdilution with media incubated for 24 h, agar dilution with media incubated for 24 or 48 h, and E test with media incubated for 24 or 48 h. When the results for the two agar screen methods that used media (Synergy Quad Plate or the in-house-prepared agar plate) were compared to the vancomycin resistance genotype, very major errors ( 2%) occurred only with Enterococcus spp. that carried vanc genes. Unacceptably high frequencies ( 1%) of very major errors occurred when results for disk diffusion with agar or the Vitek method were compared to the vancomycin genotype. Unacceptable frequencies of very major errors ( 1%) occurred with all methods for which media were used. Minor interpretive errors (susceptible or resistant strains misinterpreted as intermediately susceptible) were frequent with all methods. These minor interpretive errors also occurred most frequently with Enterococcus isolates that contained vanc genes which encoded low-level vancomycin resistance (MIC 8 g/ml) as opposed to those isolates which carried the vana or vanb gene, both of which encoded highlevel vancomycin resistance (MIC 64 g/ml) (Tables 1 and 4). DISCUSSION

3 3260 KOHNER ET AL. J. CLIN. MICROBIOL. rently, the NCCLS recommends media for the agar screen method (5, 6). The reliability of the agar screen method for detecting highlevel vancomycin resistance in Enterococcus spp. has been demonstrated. By using 6 g of vancomycin per ml of agar incubated for a full 24 h, Swenson and colleagues (10) demonstrated that this method was 96 to 99% sensitive and 100% specific for the detection of vancomycin resistance among 158 clinical isolates of Enterococcus spp. tested at eight different medical centers. The reliability of other conventional methods for detecting vancomycin resistance in Enterococcus spp., i.e., disk diffusion, agar dilution, and the recently introduced diffusion gradient method, the E test, is less clear (9, 11). However, problems appear to be most frequent when low-level vancomycin resistance, such as occurs with resistance encoded by the vanc gene group, is encountered. These methods have been studied with media as recommended by the NCCLS (4 6) instead of media as recommended by the NCCLS for the agar screen method (5, 6). One limitation of all of the above studies may be the inconsistent definition for the gold standard or reference susceptibility result. Some investigators have compared test results of the study method to a broth dilution result (11, 13), while others have compared the results of the study method to results obtained by using either agar dilution (9, 14), disk diffusion (15), the Micro Scan Rapid method (15, 16), or E-test method (12) or by comparing results to the vancomycin resistance genotype (3, 10, 11). Furthermore, for two of these studies, evaluations were limited to Enterococcus isolates with high-level vancomycin resistance (3, 12). For the current study, we compared the results of the test methods to the vancomycin resistance genotype. We also compared the performance characteristics of media and the NCCLS-recommended media for detection of vancomycin resistance by the agar dilution or disk diffusion method or CA media (4 6) by the microbroth dilution method. Furthermore, we evaluated the effects of 24 versus 48 h of incubation. The results of our study suggest that the optimal phenotypic method for determining vancomycin resistance in Enterococcus spp. is any one of the following: broth dilution with media incubated for 24 h, agar dilution with media incubated for 24 h, or the E test with media incubated for 24 h. Poorer results occurred for all of the methods when media were used. In all cases in which the incubation periods were extended to 48 h, either no difference or poorer results were obtained. Both the disk diffusion and Vitek methods produced unacceptably high numbers of very major errors (i.e., exceeding 1.0%). Growth failures did not occur with media for any method. In contrast, six growth failures occurred with media incubated for 24 or 48 h (two with microbroth dilution, one with agar dilution, two with E test, and one with disk diffusion). Moreover, the growth of Enterococcus spp. on agar plates (in-house-prepared agar screen plates, agar dilution, E test, and disk diffusion) was more luxuriant and therefore easier to read than agar plates. All of the test methods produced considerable minor errors (minor errors could not be calculated for agar screen plates when results were compared to the vancomycin resistance genotype). These minor errors could be lessened if NCCLS breakpoints for the interpretive categories, susceptible, intermediately susceptible, and resistant, are changed, especially for the Enterococcus spp. with the vanc genes that encode lowerlevel vancomycin resistance. However, the clinical significance of this lower-level resistance remains unknown. One approach might be to identify motile Enterococcus spp. and then apply TABLE 2. Test methods used in this study a Bacterial inoculum Interpretation c Test materials (commercial Vancomycin source when applicable) b concn(s) tested Method Agar screen 1. Synergy Quad Plate ( agar) (Remel) 6 g/ml 10 6 CFU/spot d Resistance defined as 1 colony 2. agar 3. agar 50 l of10 3 dilution of 0.5 Resistant, 32 g/ml; intermediate, McFarland standard d 8 16 g/ml; susceptible, 4 g/ml Enterococcus breakpoint strip: 16, 4 g/ml Broth microdilution 1. Sensititre Just One Strip (AccuMed International, Inc.) with broth 2. Sensititre Just One Strip with CA broth d Agar dilution 1. agar 16 to 2 g/ml 10 4 CFU/spot d Resistant, 32 g/ml; intermediate, 2. agar d 8 16 g/ml; susceptible, 4 g/ml Antimicrobic gradient 1. Epsilometer test (E test; AB BIODISK) with agar 256 to g/ml 0.5 McFarland standard Resistant, 32 g/ml; intermediate, 2. E test with agar 8 16 g/ml; susceptible, 4 g/ml Disk diffusion 1. agar 30- g disk 0.5 McFarland standard e Resistant, 14 mm; intermediate, 2. agar e mm; susceptible, 17 mm Automated 1. Vitek (biomerieux) with GPS-SA and R02.03 software 32 to 0.5 g/ml a For all methods excluding the Vitek method, incubation was carried out at 35 C without added CO2. b refers to brain heart infusion, refers to Mueller-Hinton, and CA refers to cation-adjusted. All media with the exception of the Synergy Quad Plate and Vitek Card were prepared in-house at the Mayo Clinical Microbiology Laboratory. c For all methods excluding the Vitek method, the results were interpreted at 24 and 48 h, according to NCCLS standard M100-S6 (6). For disk diffusion, the diameters of zones of inhibition are shown. d Media and/or bacterial inoculum prepared according to NCCLS standard M7-A3 (5). e Media and/or bacterial inoculum prepared according to NCCLS standard M2-A5 (4).

4 TABLE 3. Interpretive discrepancies by the various test methods for different Enterococcus strains with the vancomycin resistance genotype as the reference standard Interpretive discrepancy b by method: Enterococcus species (no. of strains) Type of interpretive discrepancy a Synergy Quad Plate () Agar screen Broth microdilution (Sensititre) Agar dilution E Test Disk diffusion Vitek 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h E. faecalis (34) Very major 0/5 (0) 0/5 (0) 0/5 (0) 0/5 (0) 0/5 (0) 1/5 (20) 0/5 (0) 0/5 (0) 1/5 (20) 1/5 (20) Major 0/29 (0) 0/29 (0) 0/29 (0) 0/29 (0) 0/29 (0) 0/29 (0) 0/29 (0) 1/29 (3) 0/27 (0) 0/27 (0) Minor NA NA NA NA NA NA 2/34 (6) 4/34 (12) 1/32 (3) 0/32 (0) 0/5 (0) 0/5 (0) 1/5 (20) 1/5 (20) 0/5 (0) 0/5 (0) 1/5 (20) 0/5 (0) 1/5 (20) 0/5 (20) 1/5 (20) 1/5 (20) 1/5 (20) 0/29 (0) 0/29 (0) 0/28 (0) 0/28 (0) 0/29 (0) 0/29 (0) 0/27 (0) 0/27 (0) 0/29 (0) 0/29 (0) 0/28 (0) 0/28 (0) 0/29 (0) 2/34 (6) 2/34 (6) 0/33 (0) 0/33 (0) 5/34 (15) 11/34 (32) 2/32 (6) 2/32 (6) 16/34 (47) 13/34 (38) 0/33 (0) 0/33 (0) 0/32 (0) E. faecium (43) Very major 0/39 (0) 0/39 (0) 0/39 (0) 0/39 (0) 1/39 (3) 1/39 (3) 0/39 (0) 0/39 (0) 1/38 (3) 1/38 (3) Major 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) Minor NA NA NA NA NA NA 3/43 (7) 4/43 (9) 0/42 (0) 0/42 (0) 0/39 (0) 0/39 (0) 1/39 (3) 1/39 (3) 0/39 (0) 0/39 (0) 0/39 (0) 0/39 (0) 0/39 (0) 0/39 (0) 1/39 (3) 1/39 (3) 2/38 (5) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/3 (0) 1/43 (2) 1/43 (2) 0/43 (0) 0/43 (0) 2/43 (5) 1/43 (2) 1/43 (2) 1/43 (2) 2/43 (5) 1/43 (2) 0/43 (0) 0/43 (0) 0/42 (0) E. casseliflavus/ flavescens (10) Very major 0/8 (0) 0/8 (0) 0/8 (0) 0/8 (0) 8/8 (100) 8/8 (100) 0/8 (0) 0/8 (0) 8/8 (100) 7/8 (88) 0/8 (0) 0/8 (0) 8/8 (100) 6/8 (75) 0/8 (0) 0/8 (0) 5/8 (62) 3/8 (38) 0/8 (0) 0/8 (0) 8/8 (100) 8/8 (100) 3/7 (43) Major 2/2 (100) 2/2 (100) 2/2 (100) 2/2 (100) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) 0/2 (0) Minor NA NA NA NA NA NA 10/10 (100) 10/10 (100) 0/10 (0) 1/10 (10) 10/10 (100) 10/10 (100) 0/10 (100) 2/10 (20) 10/10 (100) 10/10 (100) 4/10 (40) 6/10 (60) 9/10 (90) 9/10 (90) 0/10 (10) 0/10 (0) 6/9 (67) E. gallinarum (11) Very major 1/11 (9) 0/11 (0) 1/11 (9) 1/11 (9) 6/11 (55) 5/11 (45) 0/11 (0) 0/11 (0) 8/11 (73) 7/11 (64) 0/11 (0) 0/11 (0) 5/11 (45) 5/11 (45) 0/11 (0) 0/11 (0) 1/11 (9) 0/11 (0) 4/11 (36) 5/11 (45) 10/11 (91) 9/10 (90) 1/11 (9) Major Minor NA NA NA NA NA NA 10/11 (91) 10/11 (91) 2/11 (18) 3/11 (27) 10/11 (91) 10/11 (91) 5/11 (45) 5/11 (45) 10/11 (91) 10/11 (91) 9/11 (82) 10/11 (91) 6/11 (55) 5/11 (45) 0/11 (0) 0/11 (0) 8/11 (73) a Interpretive discrepancies are as follows: very major, resistant strain misinterpreted as susceptible (false-susceptible result); major, susceptible strain misinterpreted as resistant (false-resistant result) (since all E. gallinarium strains carried van resistance genes, they were defined as resistant, and therefore major errors could not exist); minor, resistant or susceptible strain misinterpreted as intermediately susceptible. b The enterococcal strains were incubated for 24 or 48 h, as indicated. For very major interpretive discrepancies, the number of very major errors is shown before the slash, the total number of resistant strains tested (some strains did not grow or were not tested) is shown after the slash, and the percentage of very major errors is shown in parentheses. For major interpretive discrepancies, the number of major errors is shown before the slash, the total number of susceptible strains tested (some strains did not grow or were not tested) is shown after the slash, and the percentage of major errors is shown in parentheses. For minor interpretive discrepancies, the number of minor errors is shown before the slash, the total number of resistant and susceptible strains (some strains did not grow or were not tested) is shown after the slash, and the percentage of intermediate errors is shown in parentheses. NA, not applicable (the agar screen method produces either a resistant or susceptible interpretive result only, so minor interpretive errors cannot be determined). 3261

5 3262 KOHNER ET AL. J. CLIN. MICROBIOL. TABLE 4. Summary of interpretive errors for all Enterococcus spp. Method, medium, and genes Interpretive error a Very major Major Minor 24 h 48 h 24 h 48 h 24 h 48 h Agar screen Synergy Quad vana, b vanb b 0/43 (0) 0/43 (0) vanc c 1/20 (5) 0/20 (0) No van genes d 2/37 (5) 2/37 (5) vana b, vanb b 0/43 (0) 0/43 (0) vanc c 1/20 (5) 0/20 (5) No van genes d 2/37 (5) 2/37 (5) vana, b vanb b 0/43 (0) 0/43 (0) vanc c 15/20 (75) 15/20 (75) No van genes d 0/37 (0) 0/37 (0) Broth microdilution vana, b vanb b 0/43 (0) 0/43 (0) 3/43 (7) 3/43 (7) vanc c 0/20 (0) 0/20 (0) 20/20 (100) 20/20 (100) No van genes d 0/37 (0) 1/37 (3) 2/37 (5) 5/37 (14) vana, b vanb b 0/42 (0) 0/42 (0) 1/42 (2) 0/42 (0) vanc c 18/20 (90) 16/20 (80) 2/20 (10) 4/20 (20) No van genes d 0/35 (0) 0/35 (0) 0/35 (0) 0/35 (0) Agar dilution vana, b vanb b 0/43 (0) 0/43 (0) 0/43 (0) 0/43 (0) vanc c 0/20 (0) 0/20 (0) 20/20 (100) 20/20 (100) No van genes d 0/37 (0) 0/37 (0) 3/37 (8) 3/37 (8) vana, b vanb b 0/43 (0) 0/43 (0) 0/43 (0) 0/43 (0) vanc c 15/20 (75) 13/20 (65) 5/20 (25) 7/20 (35) No van genes d 0/36 (0) 0/36 (0) 0/36 (0) 0/36 (0) E test vana, b vanb b 0/43 (0) 0/43 (0) 1/43 (2) 0/43 (0) vanc c 0/20 (0) 0/20 (0) 20/20 (100) 20/20 (20) No van genes d 0/37 (0) 0/37 (0) 6/37 (16) 12/37 (32) vana, b vanb b 1/43 (2) 0/43 (0) 0/43 (0) 0/43 (0) vanc c 7/20 (35) 3/20 (15) 14/20 (70) 17/20 (85) No van genes d 0/35 (0) 0/35 (0) 2/35 (0) 2/35 (0) Disk diffusion vana, b vanb b 0/43 (0) 0/43 (0) 1/43 (2) 0/43 (0) vanc c 5/20 (25) 5/20 (25) 15/20 (75) 15/20 (75) No van genes d 0/37 (0) 0/37 (0) 17/37 (46) 13/37 (51) vana, b vanb b 0/43 (0) 0/43 (0) 0/43 (0) 0/43 (0) vanc c 20/20 (100) 19/19 (100) 0/20 (0) 0/20 (0) No van genes d 0/36 (0) 0/36 (0) 0/36 (0) 0/36 (0) Vitek vana, b vanb b 3/42 (7) 0/42 (0) vanc c 4/19 (21) 12/19 (63) No van genes d 0/35 (0) 2/33 (6) a Interpretive errors are as follows: very major, resistant strain misinterpreted as susceptible (false-susceptible result); major, susceptible strain misinterpreted as resistant (false-resistant result); minor, resistant or susceptible strain misinterpreted as intermediately susceptible. The enterococcal strains were incubated for 24 or 48 h, as indicated, for all methods except Vitek. The number of strains with errors is shown before the slash, the number of strains studied is shown after the slash, and the percentage of strains with errors is shown in parentheses. b One isolate (E. gallinarum) contained both vana and vanc-1 genes. Two isolates (E. faecalis) had PCR amplicons with DNA sequences closely related to the vanb gene. Vancomycin MICs for all isolates with vana or vanb genes were 64 g/ml. c Vancomycin MICs for isolates containing vanc genes ranged from 4 to 8 g/ml. d Vancomycin MICs ranged from 2 to4 g/ml.

6 VOL. 35, 1997 TESTING SUSCEPTIBILITIES OF ENTEROCOCCI TO VANCOMYCIN 3263 different breakpoint guidelines as motile Enterococcus spp. (E. casseliflavus, E. flavescens, and E. gallinarum) often carry vanc genes which encode low-level vancomycin resistance. However, as we have shown (Table 1), two of the isolates evaluated in the current study were nonmotile, one E. faecium and one E. faecalis, yet carried the vanc-1 gene and had low-level resistance (MICs 8 and 4 g/ml, respectively). Until further clinical information becomes available, we would favor modification of NCCLS breakpoints to resolve this problem. It is generally recommended that resistant enterococci that grow on agar screen plates be confirmed by an MIC method (4). The current study demonstrates that two conventional confirmatory MIC methods, broth dilution and agar dilution if used with, and not as recommended by the NCCLS, adequately detect vancomycin resistance. In settings where the prevalence of vancomycin resistance is high, we feel the current study demonstrates that it is unnecessary to use the agar screen method when microbroth dilution, agar dilution, and the epsilometer tests are established susceptibility testing methods in the clinical microbiology laboratory and these methods are modified to use media. Furthermore, the current formulation of the agar screen which contains 6 g of vancomycin per ml may not detect low-level resistance vanc genotypes. ACKNOWLEDGMENT We thank R. Kondert for help in preparing the manuscript. REFERENCES 1. Evers, S., F. Sahm, and P. Courvalin The vanb gene of vancomycinresistant Enterococcus faecalis V583 is structurally related to the genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins vana and vanc. Gene 124: Evers, S., E. Reynolds, and P. Courvalin Sequence of the vanb and ddl genes encoding D-alanine:D-lactate and D-alanine:D-alanine ligases in vancomycin-resistant Enterococcus faecalis V583. Gene 140: Free, L., and D. F. Sahm Investigation of the reformulated Remel Synergy Quad Plate for detection of high-level aminoglycoside and vancomycin resistance among enterococci. J. Clin. Microbiol. 33: National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa. 5. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa. 6. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing. Sixth informational supplement M100-S6. National Committee for Clinical Laboratory Standards, Villanova, Pa. 7. Navarro, F., and P. Courvalin Analysis of genes encoding D-alanine- D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob. Agents Chemother. 38: Patel, R., J. R. Uhl, P. Kohner, M. K. Hopkins, and F. R. Cockerill III Multiplex PCR detection of vana, vanb, vanc-1, and vanc-2/3 genes in enterococci. J. Clin. Microbiol. 35: Schulz, J. E., and D. F. Sahm Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp. J. Clin. Microbiol. 31: Swenson, J. M., N. C. Clark, M. J. Ferraro, D. F. Sahm, G. Doern, M. A. Pfaller, L. B. Reller, M. P. Weinstein, R. J. Zabransky, and F. C. Tenover Development of a standardized screening method for detection of vancomycin-resistant enterococci. J. Clin. Microbiol. 32: Tenover, F. C., J. M. Swenson, C. M. O Hara, and S. A. Stocker Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J. Clin. Microbiol. 33: Van Horn, K. G., C. A. Gedris, K. M. Rodney, and J. B. Mitchell Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci. J. Clin. Microbiol. 34: Willey, B. M., B. N. Kreiswirth, A. E. Simor, G. Williams, S. R. Scriver, A. Phillips, and D. E. Low Detection of vancomycin resistance in Enterococcus species. J. Clin. Microbiol. 30: Willey, B. M., B. N. Kreiswirth, A. E. Simor, Y. Faur, M. Patel, G. Williams, and D. E. Low Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1. J. Clin. Microbiol. 31: Zabransky, R. J., A. R. DiNuzzo, M. B. Huber, and G. L. Woods Detection of vancomycin resistance in enterococci by the Vitek AMS System. Diagn. Microbiol. Infect. Dis. 20: Zabransky, R. J., A. R. Dinuzzo, and G. L. Woods Detection of vancomycin resistance in enterococci by the Alamar MIC system. J. Clin. Microbiol. 33:

Spectrum of vancomycin and susceptibility testing

Spectrum of vancomycin and susceptibility testing Spectrum of vancomycin and susceptibility testing Olivier Denis Service de Microbiologie Laboratoire de bactériologie Service de Microbiologie Hôpital Erasme Glycopeptides Vancomycin 1958 < Amycolatopsis

More information

ORIGINAL ARTICLE. Italy

ORIGINAL ARTICLE. Italy ORIGINAL ARTICLE Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies M. E. Jones

More information

Surveillance of Enterococci in Belgium. M. Ieven, K. Loens, B. Jans and H. Goossens

Surveillance of Enterococci in Belgium. M. Ieven, K. Loens, B. Jans and H. Goossens Surveillance of Enterococci in Belgium M. Ieven, K. Loens, B. Jans and H. Goossens Surveillance of Enterococci in Belgium Overview Introduction and epidemiological surveillance Results of isolates received

More information

Validation of Vitek version 7.01 software for testing staphylococci against vancomycin

Validation of Vitek version 7.01 software for testing staphylococci against vancomycin Diagnostic Microbiology and Infectious Disease 43 (2002) 135 140 www.elsevier.com/locate/diagmicrobio Validation of Vitek version 7.01 software for testing staphylococci against vancomycin P.M. Raney a,

More information

h g o Klare, Dietlitide Badstiibner, Carola Koristabel atid WoEfgang Witte

h g o Klare, Dietlitide Badstiibner, Carola Koristabel atid WoEfgang Witte ORIGINAL ARTICLE Identification of enterococci and determination of their glycopeptide resistance in German and Austrian clinical microbiology laboratories Clin Microbial Infect 1999; 5: 535-539 h g o

More information

Steven D. Brown* and Maria M. Traczewski. The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070

Steven D. Brown* and Maria M. Traczewski. The Clinical Microbiology Institute, 9725 SW Commerce Circle, Wilsonville, Oregon 97070 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2010, p. 2063 2069 Vol. 54, No. 5 0066-4804/10/$12.00 doi:10.1128/aac.01569-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Comparative

More information

SURVEILLANCE FOR GLYCOPEPTIDE-RESISTANT ENTEROCOCCI

SURVEILLANCE FOR GLYCOPEPTIDE-RESISTANT ENTEROCOCCI SURVEILLANCE FOR GLYCOPEPTIDE-RESISTANT ENTEROCOCCI Drs N Bosman, T Nana & C Sriruttan CMID NHLS Dr Charlotte Sriruttan SASCM 3/11 GLOBAL DATA VRE first isolated in Europe in 1987, (Leclercq R., et al

More information

Sri Lankan Journal of Infectious Diseases 2018 Vol.8(2): DOI: /sljid.v8i2.8221

Sri Lankan Journal of Infectious Diseases 2018 Vol.8(2): DOI: /sljid.v8i2.8221 115 Research article Epidemiology of invasive infections caused by vancomycin sensitive and resistant enterococcal strains among oncology patients at the National Cancer Institute of Sri Lanka from 1st

More information

of glycopeptide-resistant enterococci

of glycopeptide-resistant enterococci ~ ORIGINAL ARTICLE Comparison of agar-based media for primary isolation of glycopeptide-resistant enterococci l? R. Chadwickl, D. E]. Brown2, M. H. Wilcox2, T A. Collynsl, E. Walpo1e2, J. Dillon, R. Smith2,

More information

Why some tests are no longer recommended

Why some tests are no longer recommended 8 th July 2014 Why some tests are no longer recommended Robin A Howe, Cardiff, UK Antimicrobial use in Primary Care Tests that are no longer recommended Burkholderia cepacia complex testing Stenotrophomonas

More information

Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL

Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL 3 rd joint meeting on AMR in Salmonella and Campylobacter, Copenhagen 7 April 2017 Antimicrobial

More information

EUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator

EUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator EUCAST Frequently Asked Questions Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator Erika Matuschek EUCAST Development Laboratory, Växjö Sweden Monday 24

More information

Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates

Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1489 1494 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.02302-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Performance

More information

Received 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005

Received 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005 Journal of Antimicrobial Chemotherapy (2005) 56, 1047 1052 doi:10.1093/jac/dki362 Advance Access publication 20 October 2005 Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity,

More information

Clinical Failure of Vancomycin Treatment of Staphylococcus aureus Infection in a Tertiary Care Hospital in Southern Brazil

Clinical Failure of Vancomycin Treatment of Staphylococcus aureus Infection in a Tertiary Care Hospital in Southern Brazil 224 BJID 2003; 7 (June) Clinical Failure of Vancomycin Treatment of Staphylococcus aureus Infection in a Tertiary Care Hospital in Southern Brazil Larissa Lutz, Adão Machado, Nadia Kuplich and Afonso Luís

More information

Methods for AST: diffusion or dilution? (pro s en con s)

Methods for AST: diffusion or dilution? (pro s en con s) 7 th EURL-AR workshop 4-5 April 2013 DTU, Kgs. Lyngby, Denmark Methods for AST: diffusion or dilution? (pro s en con s) Kees Veldman Introduction Work as a senior technician at the Central Veterinary Institute

More information

Report: antimicrobial resistance in commensal Enterococcus spp. from poultry, pigs, cows and veal calves

Report: antimicrobial resistance in commensal Enterococcus spp. from poultry, pigs, cows and veal calves Veterinary and Agrochemical Research Centre Report: antimicrobial resistance in commensal Enterococcus spp. from poultry, pigs, cows and veal calves P. Butaye 1 Introduction Enterococci are regarded as

More information

RAPID COMMUNICATION. Maura S. de Oliveira, I Silvia Figueiredo Costa, II Ewerton de Pedri, II Inneke van der Heijden, II Anna Sara S.

RAPID COMMUNICATION. Maura S. de Oliveira, I Silvia Figueiredo Costa, II Ewerton de Pedri, II Inneke van der Heijden, II Anna Sara S. RAPID COMMUNICATION The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam

More information

Resistance among Streptococcus pneumoniae Clinical Isolates by Use of the E Test

Resistance among Streptococcus pneumoniae Clinical Isolates by Use of the E Test JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1994, p. 159-163 0095-1137/94/$04.00+0 Copyright 1994, American Society for Microbiology Vol. 32, No. 1 Detection of Penicillin and Extended-Spectrum Cephalosporin

More information

Received 12 December 2010/Returned for modification 5 January 2011/Accepted 16 March 2011

Received 12 December 2010/Returned for modification 5 January 2011/Accepted 16 March 2011 JOURNAL OF CLINICAL MICROBIOLOGY, May 2011, p. 1765 1771 Vol. 49, No. 5 0095-1137/11/$12.00 doi:10.1128/jcm.02517-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Multicenter

More information

An evaluation of 2.0 McFarland Etest method for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus

An evaluation of 2.0 McFarland Etest method for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus Asian Biomedicine Vol. 4 No. 1 February 2010; 141-145 Brief communication (Original) An evaluation of 2.0 McFarland Etest method for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus

More information

(multidrug-resistant Pseudomonas aeruginosa; MDRP)

(multidrug-resistant Pseudomonas aeruginosa; MDRP) 220 2009 (multidrug-resistant Pseudomonas aeruginosa; MDRP) 21 4 1 21 10 4 amikacin (AMK), imipenem/cilastatin (IPM), ciprofloxacin (CPFX) multidrug-resistant Pseudomonas aeruginosa (MDRP) CHROMagar TM

More information

Comparison of the BD GeneOhm VanR Assay to Culture for Identification of Vancomycin-Resistant Enterococci in Rectal and Stool Specimens

Comparison of the BD GeneOhm VanR Assay to Culture for Identification of Vancomycin-Resistant Enterococci in Rectal and Stool Specimens JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 2007, p. 3360 3365 Vol. 45, No. 10 0095-1137/07/$08.00 0 doi:10.1128/jcm.01458-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Comparison

More information

ACCEPTED. Comparison of disk diffusion and agar dilution methods for erythromycin and

ACCEPTED. Comparison of disk diffusion and agar dilution methods for erythromycin and AAC Accepts, published online ahead of print on January 00 Antimicrob. Agents Chemother. doi:./aac.000-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

What is new in EUCAST South Africa, May, Gunnar Kahlmeter EUCAST Technical Data Coordinator and Webmaster Sweden

What is new in EUCAST South Africa, May, Gunnar Kahlmeter EUCAST Technical Data Coordinator and Webmaster Sweden What is new in EUCAST 2016 17 South Africa, May, 2016 Gunnar Kahlmeter EUCAST Technical Data Coordinator and Webmaster Sweden What is new in EUCAST 2016/17? New organisms with breakpoints (Addendum 2016)

More information

In Vitro Susceptibilities of Aerobic and Facultative Non-Spore- Forming Gram-Positive Bacilli to HMR 3647 (RU 66647) and 14 Other Antimicrobials

In Vitro Susceptibilities of Aerobic and Facultative Non-Spore- Forming Gram-Positive Bacilli to HMR 3647 (RU 66647) and 14 Other Antimicrobials ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1998, p. 1028 1033 Vol. 42, No. 5 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology In Vitro Susceptibilities of Aerobic and Facultative

More information

Proficiency of Clinical Laboratories in Spain in Detecting Vancomycin-Resistant Enterococcus spp.

Proficiency of Clinical Laboratories in Spain in Detecting Vancomycin-Resistant Enterococcus spp. JOURNAL OF CLINICAL MICROBIOLOGY, July 1999, p. 2148 2152 Vol. 37, No. 7 0095-1137/99/$04.00 0 Proficiency of Clinical Laboratories in Spain in Detecting Vancomycin-Resistant Enterococcus spp. JUAN ALONSO-ECHANOVE,

More information

Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory

Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory Dr Danièle Meunier, AMRHAI BSAC - Antimicrobial Susceptibility Testing User Days Oxazolidinone Linezolid

More information

Best Practice of in vitro Methods on Measuring Anti Microbial of Chemical Substance on Root Canal Treatment: Literature Review

Best Practice of in vitro Methods on Measuring Anti Microbial of Chemical Substance on Root Canal Treatment: Literature Review Best Practice of in vitro Methods on Measuring Anti Microbial of Chemical Substance on Root Canal Treatment: Literature Review Dani Rizali Firman 1, Indra Primathena 2 1 Oral Biology Department, Faculty

More information

Testing for Induction of Clindamycin Resistance in Erythromycin-Resistant Isolates of Staphylococcus aureus

Testing for Induction of Clindamycin Resistance in Erythromycin-Resistant Isolates of Staphylococcus aureus JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2005, p. 1716 1721 Vol. 43, No. 4 0095-1137/05/$08.00 0 doi:10.1128/jcm.43.4.1716 1721.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.

More information

In Vitro Susceptibility of Staphylococci and Enterococci to Vancomycin and Teicoplanin

In Vitro Susceptibility of Staphylococci and Enterococci to Vancomycin and Teicoplanin In Vitro Susceptibility of Staphylococci and Enterococci to Vancomycin and Teicoplanin 19 A. Guzek, K. Korzeniewski, Aneta Nitsch-Osuch, Z. Rybicki, and E. Prokop Abstract Hospital-acquired infections

More information

Identification of vat(e) in Enterococcus faecalis Isolates from Retail Poultry and Its Transferability to Enterococcus faecium

Identification of vat(e) in Enterococcus faecalis Isolates from Retail Poultry and Its Transferability to Enterococcus faecium ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2002, p. 3823 3828 Vol. 46, No. 12 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.12.3823 3828.2002 Identification of vat(e) in Enterococcus faecalis Isolates from

More information

Table 1. Antifungal Breakpoints for Candida. 2,3. Agent S SDD or I R. Fluconazole < 8.0 mg/ml mg/ml. > 64 mg/ml.

Table 1. Antifungal Breakpoints for Candida. 2,3. Agent S SDD or I R. Fluconazole < 8.0 mg/ml mg/ml. > 64 mg/ml. AUSTRALIAN ANTIFUNGAL SUSCEPTIBILITY DATA 2008-2011 Part 1: The Yeasts In this article, an update of recent changes to the CLSI antifungal standards for susceptibility testing of yeasts is presented. We

More information

The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland

The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland Journal of Antimicrobial Chemotherapy (2002) 50, 1065 1069 DOI: 10.1093/jac/dkf252 The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland Jolanta Krzysztoá-Russjan

More information

Ueli von Ah, Dieter Wirz, and A. U. Daniels*

Ueli von Ah, Dieter Wirz, and A. U. Daniels* JOURNAL OF CLINICAL MICROBIOLOGY, June 2008, p. 2083 2087 Vol. 46, No. 6 0095-1137/08/$08.00 0 doi:10.1128/jcm.00611-08 Copyright 2008, American Society for Microbiology. All Rights Reserved. Rapid Differentiation

More information

Received 25 September 2006/Returned for modification 4 December 2006/Accepted 26 December 2006

Received 25 September 2006/Returned for modification 4 December 2006/Accepted 26 December 2006 JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2007, p. 796 802 Vol. 45, No. 3 0095-1137/07/$08.00 0 doi:10.1128/jcm.01986-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Multicenter

More information

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae AAC Accepted Manuscript Posted Online 26 January 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.04127-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 In vitro assessment

More information

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin

More information

Synergy of beta-lactams with vancomycin against methicillin-resistant. Staphylococcus aureus: correlation of the disk diffusion and the

Synergy of beta-lactams with vancomycin against methicillin-resistant. Staphylococcus aureus: correlation of the disk diffusion and the JCM Accepted Manuscript Posted Online 16 December 2015 J. Clin. Microbiol. doi:10.1128/jcm.01779-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 3 Synergy of beta-lactams

More information

Haemophilus influenzae from four laboratories in one Canadian City

Haemophilus influenzae from four laboratories in one Canadian City Journal of Antimicrobial Chemotherapy (988), -9 Haemophilus influenzae from four laboratories in one Canadian City Julie Righter" and Ingrid Luchstnger* 'Department of Microbiology, University of Toronto;

More information

Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone

Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone Zurenko et al. Annals of Clinical Microbiology and Antimicrobials 2014, 13:46 RESEARCH Open Access Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens

More information

1* 1. Vijaya S. Rajmane, Shivaji T. Mohite

1* 1. Vijaya S. Rajmane, Shivaji T. Mohite ISSN 2231-4261 ORIGINAL ARTICLE Comparison of the VITEK 2 Yeast Antifungal Susceptibility ing with CLSI Broth Microdilution Reference for ing Four Antifungal Drugs against Candida species Isolated from

More information

Vancomycin MIC for Methicillin-Resistant Coagulase-Negative Staphylococcus. sp.: Evaluation of the Broth Microdilution and Etest Methods

Vancomycin MIC for Methicillin-Resistant Coagulase-Negative Staphylococcus. sp.: Evaluation of the Broth Microdilution and Etest Methods JCM Accepts, published online ahead of print on 22 September 2010 J. Clin. Microbiol. doi:10.1128/jcm.01182-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

Evaluation of Antibacterial Effect of Odor Eliminating Compounds

Evaluation of Antibacterial Effect of Odor Eliminating Compounds Evaluation of Antibacterial Effect of Odor Eliminating Compounds Yuan Zeng, Bingyu Li, Anwar Kalalah, Sang-Jin Suh, and S.S. Ditchkoff Summary Antibiotic activity of ten commercially available odor eliminating

More information

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Objectives: To discuss the guidelines for detection of CRE in the laboratory setting. To review

More information

Comparision of Antibiotic Susceptibility Testing As Per CLSI and Eucast Guidelines for Gram Negative Bacilli

Comparision of Antibiotic Susceptibility Testing As Per CLSI and Eucast Guidelines for Gram Negative Bacilli IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 7 Ver. X (July. 2016), PP 01-05 www.iosrjournals.org Comparision of Antibiotic Susceptibility

More information

Nebraska Public Health Laboratory Newsletter

Nebraska Public Health Laboratory Newsletter Nebraska Public Health Laboratory Newsletter A publication of the Nebraska Public Health Laboratory (NPHL) at the University of Nebraska Medical Center Summer/Fall 1998 Introduction: This issue of our

More information

ORIGINAL INVESTIGATION. Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City

ORIGINAL INVESTIGATION. Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City ORIGINAL INVESTIGATION Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City A New Threat to Our Antibiotic Armamentarium Simona Bratu, MD; David Landman, MD; Robin Haag, RN; Rose

More information

T&T WG. June 2018 San Diego, CA

T&T WG. June 2018 San Diego, CA T&T WG June 2018 San Diego, CA Co-Chairs Jana Swenson Shelley Campeau Secretary Carey-Ann Burnham Members Andrea Ferrell Janet Hindler Melissa Jones Peggy Kohner Dyan Luper Linda Mann Susan Munro Barth

More information

Sensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase

Sensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase JCM Accepts, published online ahead of print on 19 October 2011 J. Clin. Microbiol. doi:10.1128/jcm.05602-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

Screening and detection of carbapenemases

Screening and detection of carbapenemases Screening and detection of carbapenemases For many isolates with carbapenemases the MICs of carbapenems are around the susceptible breakpoint making resistance difficult to detect - particularly with automated

More information

Methodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa

Methodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa Methodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa Y. Glupczynski Laboratoire de bactériologie Cliniques Universitaires UCL de Mont-Godinne Université Catholique

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Factors influencing the results of metronidazole resistance testing Elisabeth Nagy Institute of Clinical Microbiology, University of Szeged, National Anaerobe Reference Laboratory, Szeged, Hungary Postgraduate

More information

EPIDEMIOLOGY AND CONTROL OF THE FIRST REPORTED VANCOMYCIN-RESISTANT ENTEROCOCCUS OUTBREAK AT A TERTIARY-CARE HOSPITAL IN BANGKOK, THAILAND

EPIDEMIOLOGY AND CONTROL OF THE FIRST REPORTED VANCOMYCIN-RESISTANT ENTEROCOCCUS OUTBREAK AT A TERTIARY-CARE HOSPITAL IN BANGKOK, THAILAND EPIDEMIOLOGY AND CONTROL OF THE FIRST REPORTED VANCOMYCIN-RESISTANT ENTEROCOCCUS OUTBREAK AT A TERTIARY-CARE HOSPITAL IN BANGKOK, THAILAND Darunee Chotiprasitsakul 1, Pitak Santanirand 2, Phantanee Thitichai

More information

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category Discussion points 2009 CLSI M100 S19 Update Nebraska Public Health Laboratory Changes most important to routine antimicrobial susceptibility testing. Documents available Janet Hindler discussion slide

More information

Experimental Endocarditis Caused by Streptococcus sanguis:

Experimental Endocarditis Caused by Streptococcus sanguis: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1981, p. 1-14 66-484/81/71-5$2./ Vol. 2, No. 1 Experimental Endocarditis Caused by Streptococcus sanguis: Single and Combined Antibiotic Therapy MARIA V. VICENTE,

More information

Report on susceptibility of Salmonella serotypes in Belgium Vicky Jasson

Report on susceptibility of Salmonella serotypes in Belgium Vicky Jasson CODA-CERVA Report on susceptibility of Salmonella serotypes in Belgium 2014. Vicky Jasson Veterinary and Agrochemical Research Centre 1 Introduction Salmonella is one of the most important bacterial zoonotic

More information

Comparative Evaluation of the API 20S and AutoMicrobic Gram- Positive Identification Systems for Non-Beta-Hemolytic Streptococci

Comparative Evaluation of the API 20S and AutoMicrobic Gram- Positive Identification Systems for Non-Beta-Hemolytic Streptococci JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1985, p. 535-541 0095-1 137/85/040535-07$02.00/0 Copyright D 1985, American Society for Microbiology Vol. 21, No. 4 Comparative Evaluation of the API 20S and AutoMicrobic

More information

Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002

Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002 Fluconazole J Microbiol Immunol susceptibility Infect of Candida 2004;37:236-241 Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002 Jiun-Ling Wang

More information

Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides

Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides Clin Pharmacokinet (2018) 57:797 816 https://doi.org/10.1007/s40262-017-0623-4 REVIEW ARTICLE Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides Valentin

More information

CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel

CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel CLINICAL USE OF GLYCOPEPTIDES Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel Glycopeptides Natural Vancomycin introduced in 1958 Teicoplanin introduced in Europe

More information

Synergism of Fosfomycin-Ampicillin and Fosfomycin-

Synergism of Fosfomycin-Ampicillin and Fosfomycin- ANTIMICROBiAL AGENTS AND CHEMoTHERAPY, May 1978, p. 75-79 66-484/78/13-75$2./ Copyright 1978 American Society for Microbiology Vol. 13, No. 5 Printed in U.S.A. Synergism of Fosfomycin-Ampicillin and Fosfomycin-

More information

Vancomycin resistance in Staphylococcus aureus

Vancomycin resistance in Staphylococcus aureus INTERNATIONAL NEWSLETTER no 3 SEPTEMBER 2002 STATE-OF-THE-ART THE BIOMERIEUX SOLUTION DID YOU KNOW? PRACTICAL ADVICE Vancomycin resistance in Staphylococcus aureus VITEK 2 performance Web site 10 th ISSSI

More information

Tigecycline activity tested against 26, 474 bloodstream infection isolates: a collection from 6 continents

Tigecycline activity tested against 26, 474 bloodstream infection isolates: a collection from 6 continents Diagnostic Microbiology and Infectious Disease 52 (2005) 181 186 www.elsevier.com/locate/diagmicrobio Tigecycline activity tested against 26, 474 bloodstream infection isolates: a collection from 6 continents

More information

Comparison of Minocycline Susceptibility Testing Methods for Carbapenem- Resistant Acinetobacter baumannii

Comparison of Minocycline Susceptibility Testing Methods for Carbapenem- Resistant Acinetobacter baumannii JCM Accepted Manuscript Posted Online 14 September 2016 J. Clin. Microbiol. doi:10.1128/jcm.01810-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 Comparison of Minocycline

More information

Received 26 March 2013; returned 21 April 2013; revised 22 July 2013; accepted 26 July 2013

Received 26 March 2013; returned 21 April 2013; revised 22 July 2013; accepted 26 July 2013 J Antimicrob Chemother 2014; 69: 211 218 doi:10.1093/jac/dkt340 Advance Access publication 29 August 2013 Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients

More information

DIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05

DIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05 Date company submitted: 15 Dec 04 Date received by CDER: 15 Dec 04 Reviewer: Fred Marsik, Ph.D. Date assigned: 15 Dec 04 NAME AND ADDRESS OF APPLICANT Wyeth Pharmaceuticals Inc. P.O. Box 8299 Philadelphia,

More information

Received 24 August 2010/Returned for modification 7 November 2010/Accepted 7 February 2011

Received 24 August 2010/Returned for modification 7 November 2010/Accepted 7 February 2011 JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1583 1587 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.01719-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Clinical and

More information

BACTERIOLOGY PROFICIENCY TESTING PROGRAM

BACTERIOLOGY PROFICIENCY TESTING PROGRAM BACTERIOLOGY PROFICIENCY TESTING PROGRAM Comprehensive Category September 6, 2016 If you have any questions or comments, please contact either: Dr. Wendy Archinal Nellie Dumas Dr. Kimberlee Musser Phone:

More information

Molecular Characterization of Vancomycin-Resistant Enterococci from Hospitalized Patients and Poultry Products in The Netherlands

Molecular Characterization of Vancomycin-Resistant Enterococci from Hospitalized Patients and Poultry Products in The Netherlands JOURNAL OF CLINICAL MICROBIOLOGY, July 1998, p. 1927 1932 Vol. 36, No. 7 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Molecular Characterization of Vancomycin-Resistant

More information

Received 21 July 2008/Accepted 3 September 2008

Received 21 July 2008/Accepted 3 September 2008 JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2008, p. 3585 3590 Vol. 46, No. 11 0095-1137/08/$08.00 0 doi:10.1128/jcm.01391-08 Copyright 2008, American Society for Microbiology. All Rights Reserved. Validation

More information

Received 30 November 2000/Returned for modification 10 February 2001/Accepted 24 February 2001

Received 30 November 2000/Returned for modification 10 February 2001/Accepted 24 February 2001 JOURNAL OF CLINICAL MICROBIOLOGY, May 2001, p. 1781 1787 Vol. 39, No. 5 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.5.1781 1787.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.

More information

LO GITUDI AL STUDY OF A TIMICROBIAL RESISTA CE AMO G ESCHERICHIA COLI ISOLATED FROM I TEGRATED MULTI-SITE COHORTS OF HUMA S A D SWI E.

LO GITUDI AL STUDY OF A TIMICROBIAL RESISTA CE AMO G ESCHERICHIA COLI ISOLATED FROM I TEGRATED MULTI-SITE COHORTS OF HUMA S A D SWI E. LO GITUDI AL STUDY OF A TIMICROBIAL RESISTA CE AMO G ESCHERICHIA COLI ISOLATED FROM I TEGRATED MULTI-SITE COHORTS OF HUMA S A D SWI E A Dissertation by WALID QASIM MOHAMMAD ALALI Submitted to the Office

More information

JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved.

JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved. JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p. 2575 2579 Vol. 36, No. 9 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Can Results Obtained with Commercially

More information

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 474-478 http://www.ijcmas.com Original Research Article Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

More information

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED AAC Accepts, published online ahead of print on February 00 Antimicrob. Agents Chemother. doi:./aac.01-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia JOURNAL OF CLINICAL MICROBIOLOGY, June 2004, p. 2398 2402 Vol. 42, No. 6 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.6.2398 2402.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

Author: Souha Kanj Andrew Whitelaw Michael J. Dowzicky. To appear in: International Journal of Antimicrobial Agents

Author: Souha Kanj Andrew Whitelaw Michael J. Dowzicky. To appear in: International Journal of Antimicrobial Agents t Title: In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011 Author: Souha Kanj Andrew Whitelaw

More information

Impact of rapid meca polymerase chain reaction rapid diagnostic testing for Staphylococcus aureus in a pediatric setting

Impact of rapid meca polymerase chain reaction rapid diagnostic testing for Staphylococcus aureus in a pediatric setting Butler University Digital Commons @ Butler University Undergraduate Honors Thesis Collection Undergraduate Scholarship 2018 Impact of rapid meca polymerase chain reaction rapid diagnostic testing for Staphylococcus

More information

Rapid identification and resistance assessment: The future is mass spectrometry

Rapid identification and resistance assessment: The future is mass spectrometry Rapid identification and resistance assessment: The future is mass spectrometry Dr Sanmarié Schlebusch Director of Microbiology Mater Pathology Brisbane Outline Introduction Plug and play Pre-prep and

More information

Received 26 July 2006/Returned for modification 10 October 2006/Accepted 16 October 2006

Received 26 July 2006/Returned for modification 10 October 2006/Accepted 16 October 2006 JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2007, p. 70 75 Vol. 45, No. 1 0095-1137/07/$08.00 0 doi:10.1128/jcm.01551-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Use of Fluconazole

More information

Results of Disk Diffusion Testing with Cefoxitin Correlate with Presence of meca in Staphylococcus spp.

Results of Disk Diffusion Testing with Cefoxitin Correlate with Presence of meca in Staphylococcus spp. JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2005, p. 3818 3823 Vol. 43, No. 8 0095-1137/05/$08.00 0 doi:10.1128/jcm.43.8.3818 3823.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.

More information

Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms

Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms FEMS Microbiology Letters 185 (1999) 1^7 MiniReview Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms Robin Patel * Division of Infectious Diseases and Infectious Diseases Research

More information

Determination of MIC & MBC

Determination of MIC & MBC 1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight

More information

/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved.

/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved. JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2001, p. 183 190 Vol. 39, No. 1 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.1.183 190.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Contemporary

More information

Chapter 4. Anti-bacterial studies of PUFA extracts from Sardinella longiceps and Sardinella fimbriata. 4.1 Introduction

Chapter 4. Anti-bacterial studies of PUFA extracts from Sardinella longiceps and Sardinella fimbriata. 4.1 Introduction Anti-bacterial studies of PUFA extracts from Sardinella longiceps and Sardinella fimbriata C o n t e n t s 4.1 Introduction 4.2 Materials and Methods 4.2.1 Extract Preparation and Determination of PUFA

More information

Enterococci: Emerging Drug Resistant Bacteria In Hospital Acquired Infections At Hospital Kuala Lumpur, Malaysia

Enterococci: Emerging Drug Resistant Bacteria In Hospital Acquired Infections At Hospital Kuala Lumpur, Malaysia ISPUB.COM The Internet Journal of Microbiology Volume 9 Number 2 Enterococci: Emerging Drug Resistant Bacteria In Hospital Acquired Infections At Hospital Kuala R Ibrahim, M Mohamad, M Rahman Citation

More information

Bacterial Identification

Bacterial Identification JOURNAL OF CLINICAL MICROBIOLOGY, July 1994, p. 1757-1762 0095-1137/94/$04.00+0 Copyright C 1994, American Society for Microbiology Vol. 32, No. 7 Clinical Impact of Rapid In Vitro Susceptibility Testing

More information

Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique

Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique Journal of Antimicrobial Chemotherapy (996) 7, 65-7 Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique Sharon C. A. Chen, Maryann L. O'Donnell, Suzannah

More information

OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae

OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae OUTLINE Laboratory Detection and Reporting of Streptococcus agalactiae I. Importance of prenatal screening strategies II. Past approaches Erik Munson Clinical Microbiology Wheaton Franciscan Laboratory

More information

Rifampin Resistance. Charlottesville, Virginia i0w organisms in Trypticase soy broth (BBL Microbiology

Rifampin Resistance. Charlottesville, Virginia i0w organisms in Trypticase soy broth (BBL Microbiology ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1980, p. 658-662 0066-4804/80/04-0658/05$02.00/0 Vol. 17, No. 14 Treatment of Experimental Staphylococcal Infections: Effect of Rifampin Alone and in Combination

More information

In-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria

In-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.342

More information

Received 13 September 2006/Returned for modification 6 November 2006/Accepted 26 December 2006

Received 13 September 2006/Returned for modification 6 November 2006/Accepted 26 December 2006 JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2007, p. 858 864 Vol. 45, No. 3 0095-1137/07/$08.00 0 doi:10.1128/jcm.01900-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Correlation

More information

Laboratory Detection and Reporting of Streptococcus agalactiae

Laboratory Detection and Reporting of Streptococcus agalactiae Laboratory Detection and Reporting of Streptococcus agalactiae Erik Munson Clinical Microbiology Wheaton Franciscan Laboratory Milwaukee, Wisconsin The presenter states no conflict of interest and has

More information

NONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN

NONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN NONFERMENTING GRAM NEGATIVE RODS April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic limitations to assessing carbapenem resistance in nonfermenting GNRs Discuss antimicrobial

More information

Moderate-Level Resistance to Glycopeptide LY Mediated by Genes of the vana and vanb Clusters in Enterococci

Moderate-Level Resistance to Glycopeptide LY Mediated by Genes of the vana and vanb Clusters in Enterococci ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1999, p. 1875 1880 Vol. 43, No. 8 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Moderate-Level Resistance to

More information

HOW BUGS COMBAT DRUGS: ANTIMICROBIAL RESISTANCE MECHANISMS IN THE MODERN ERA. Romney Humphries, PhD D(ABMM)

HOW BUGS COMBAT DRUGS: ANTIMICROBIAL RESISTANCE MECHANISMS IN THE MODERN ERA. Romney Humphries, PhD D(ABMM) HOW BUGS COMBAT DRUGS: ANTIMICROBIAL RESISTANCE MECHANISMS IN THE MODERN ERA Romney Humphries, PhD D(ABMM) Section Chief, UCLA Clinical Microbiology Los Angeles CA rhumphries@mednet.ucla.edu WHAT WE WILL

More information

Mupirocin Rationale for the EUCAST clinical breakpoints, version th July 2010

Mupirocin Rationale for the EUCAST clinical breakpoints, version th July 2010 Mupirocin Rationale for the EUCAST clinical breakpoints, version 1.0 6 th July 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European

More information

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Title Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong Author(s) Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Citation International Journal Of Antimicrobial Agents, 2011, v. 37 n. 4, p.

More information